Article
The structure of the humanised A33 Fab C226S variant, an immunotherapy candidate for colorectal cancer
2022-06-21
Abstract excerpt
Colorectal cancer (CRC) causes the second highest cancer-related deaths worldwide. The human A33 antigen is a validated immunotherapy target, which is homogeneously expressed in 95% cases of primary and metastatic colorectal cancers. In this article, we report the structure of a humanised antigen-binding fragment A33 (A33 Fab), a therapeutic antibody candidate, in two different crystal forms. Insights into the str...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7a68bd4-f95f-5c4a-8580-3bc8daca7c0a
- DOI
- 10.1101/2022.06.21.497004
